Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 10:52 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1753–1776 of 2,210 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Reduced Activity Clear all

Conditions: Smoking, Smoking Cessation, Adherence, Nicotine Dependence, Motivation
Interventions: Short Term Combination Nicotine Replacement Therapy (patch + gum), Long Term Combination Nicotine Replacement Therapy (patch + gum), Intensive Maintenance Counseling, Cognitive Medication Adherence Counseling (CAM), Electronic Medication Monitoring Device (the Helping Hand) + Feedback, Automated Adherence Prompting Phone Calls; Drug · Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 99 Years
Enrollment: 544 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: HIV
Interventions: MBSR Course, HEP Course; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 45 Years and older
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Nicotine Dependence, Alcohol Use
Interventions: Mindfulness Training for Smokers, Interactive Learning for Smokers; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 29 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Palsy Supranuclear, Supranuclear Palsy, Progressive
Interventions: Repetitive transcranial magnetic stimulation (rTMS); Device
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 40 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Medication Associated Metallic Taste , Dysgeusia
Interventions: Metaqil™ Oral Rinse, Placebo; Device
Lead sponsor: You First Services; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Anxiety, Depression
Interventions: External Qigong, Mindfulness Meditation, Psychoeducation; Behavioral · Other
Lead sponsor: University of South Dakota; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Obesity
Interventions: Healthy Weight for Living for Hispanics; Behavioral
Lead sponsor: Tufts University; Other
Eligibility: 50 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Orthopedic Disorder
Interventions: RF Health MAC; Device
Lead sponsor: Recovery Force LLC; Industry
Eligibility: 40 Years to 85 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: PreDiabetes
Interventions: Online diabetes prevention program, Standard Care; Behavioral
Lead sponsor: Omada Health, Inc.; Industry
Eligibility: 19 Years and older
Enrollment: 598 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Hyperphosphatemia
Interventions: PA21 (Velphoro®), Calcium Acetate (Phoslyra®); Drug
Lead sponsor: Vifor Fresenius Medical Care Renal Pharma; Industry
Eligibility: Up to 18 Years
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 22
States / cities: Birmingham, Alabama • Washington D.C., District of Columbia • Miami, Florida + 17 more

Conditions: Depressive Symptoms, Substance Use
Interventions: Arrowhead Business Group Curriculum, Recreational League Control Condition; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 13 Years to 15 Years
Enrollment: 449 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Whiteriver, Arizona

Conditions: Anger, Smoking Cessation
Interventions: Anger Reduction Treatment, Control Condition; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Chronic Disease, Obesity, Sleep Disorder, Depression
Interventions: Lifestyle Medicine; Behavioral
Lead sponsor: Ohio University; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Athens, Ohio

Conditions: Anxiety, Depression, Stress, Burnout, Emotion Regulation, Social Acceptance, Loneliness, Compassion
Interventions: Compassion Cultivation Training (CCT), Mindfulness-Based Stress Reduction (MBSR); Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 290 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Overweight, Obesity
Interventions: Initial in-person individual diet and exercise counseling (N vs. Y), Thrice weekly diet and exercise text messages (N vs. Y), Weekly telephone support (N vs. Y), Self-monitoring tools (N vs. Y) (for diet and weight); Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 1,785 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Anxiety, Cancer
Interventions: Music; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older · Female only
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Eating Disorder Symptom, Emotional Maladjustment, Negative Thoughts
Interventions: Cognitive Bias Treatment, Relaxation Condition; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Metabolic Disorders, Physical Inactivity, Vascular Disease Risk
Interventions: reduced physical activity; Other
Lead sponsor: Miami University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Oxford, Ohio

Conditions: Type 2 Diabetes Mellitus, Obesity
Interventions: Roux-en-Y Gastric Bypass Surgery, Laparoscopic Adjustable Gastric Banding, Lifestyle Weight Loss Intervention; Procedure · Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 25 Years to 55 Years
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Type 2 Diabetes Treated With Insulin, Hypoglycemia, Primary Health Care, Polypharmacy
Interventions: Conversation Aid, Attention Control Educational Handout; Behavioral · Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 75 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 4
States / cities: San Francisco, California • San Leandro, California • Union City, California + 1 more

Conditions: Stress, Mindfulness, Cognitive Change
Interventions: Enhanced Stress Resilience Training (ESRT), Active Control; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 64 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pharmacokinetic in Normal Population
Interventions: Tafenoquine Oral Tablet; Drug
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: East Syracuse, New York

Conditions: Peri-Implantitis
Interventions: Er,Cr:YSGG laser, Scaling, Inactive Er,Cr:YSGG; Device · Procedure
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Medulloblastoma
Interventions: Craniospinal Irradiation with boost to the primary tumor site, Cyclophosphamide, Cisplatin, Vincristine, Vismodegib, Pemetrexed, Gemcitabine, Aerobic Training, Neurocognitive Remediation; Radiation · Drug · Other
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 3 Years to 39 Years
Enrollment: 660 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2031
U.S. locations: 14
States / cities: Palo Alto, California • San Diego, California • New Haven, Connecticut + 11 more

Search by objective public record fields.

Evaluation of Treatments to Improve Smoking Cessation Medication Adherence

Effects of Mindfulness Training on Chronic Inflammation in HIV-Infected Adults

Pilot Study on Mindfulness for Tobacco and Alcohol in University Students

Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy

Determination of the Safety and Effectiveness of an Oral Rinse in the Reduction of Medication Associated Metallic Taste

Exploring the Efficacy of Treatments for Anxiety and Depression Among College Students

Development of Novel Behavioral Intervention for Sustainable Weight Loss in Hispanic Adults With Obesity

Wearable Technology to Reduce Risk of DVT and Increase Patient Compliance

Preventing Diabetes With Digital Health and Coaching

A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia

Evaluation of an Entrepreneurship Program for American-Indian Youth

Computerized Anger-Reduction Treatment for Smoking Cessation

Virtual Lifestyle Medicine Comparative Effectiveness Research

Compassion Training and Mindfulness Training for Social Well-Being and Mental Health

Consumption of More Ideal Food Options (COMIDA: Consumo de Opciones Más Ideales De Alimentos)

Music of Choice to Decrease Anxiety During Radiation Treatment

Testing if Reductions in Negative Affect Yield Decreased Emotional Eating Symptoms

Interactive Roles of Cardiorespiratory Fitness and Adiposity on Glucose and Vascular Control After Physical Inactivity

The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes

Reducing Treatment Risk in Older Adults With Diabetes

Enhanced Stress Resilience Training for Residents

Pharmacokinetic (PK) Study of Tafenoquine in Healthy Adults

Peri-implantitis Treatment: Clinical Results of Conventional Treatment vs. the Addition of Biolase

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma